IRIDEX
IRIX | NASDAQ
$0.67
-$0.02 (-2.90%)
At close: Nov 16, 2026, 3:59 PM ET
$0.71
+$0.04 (+6.25%)
After-hours:
Nov 16, 2026, 6:55 PM ET
-2.90%
(1D)No price chart data available for 1D timeframe.
Rating
40.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #502/1021 (Top 49%)
Key Statistics
Market Data
Market Cap $11.77M
1D Range
0.65 0.73
52W Range
0.61 1.56
Valuation (TTM)
PE -3.35
PB 3.23
EV/EBITDA -6.51
Valuation (NTM)
Forward PE 28.23
Forward PEG 0.06
Price Target $2.75
Cash Flow
FCF Yield -16.3%
SBC Adj. FCF Yield -22.5%
SBC Impact -38.0%
Margins
Gross Margin 36.2%
Operating Margin -5.4%
FCF Margin -3.7%
Growth (CAGR)
Revenue 3Y | 5Y -2.9% |
2.1%
Dil EPS 3Y | 5Y 58.0% |
20.2%
FCF 3Y | 5Y 42.7% |
25.1%
Returns
ROA -13.0%
ROE -78.9%
ROIC -19.5%
Financial Health
Net Cash
$744K
Current Ratio 1.82
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools ...
Sector Healthcare
Industry Medical - Devices
Employees 93
IPO Date Feb 16, 1996
Website www.iridex.com
Fiscal Year February - January
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove IRIX